Umbral Energy Corp Share Price Toronto S.E.
Equities
UMB
CA90420Y1088
Pharmaceuticals
Sales 2022 | 29.57 40.47 2.34K | Sales 2023 | 29.79 40.79 2.36K | Capitalization | 14.15M 19.36M 1.12B |
---|---|---|---|---|---|
Net income 2022 | -24M -32.85M -1.9B | Net income 2023 | -20M -27.38M -1.58B | EV / Sales 2022 | 1,474,984 x |
Net Debt 2022 | 11.54M 15.8M 912M | Net Debt 2023 | 4.53M 6.2M 358M | EV / Sales 2023 | 626,876 x |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Jasmine Paige
DFI | Director of Finance/CFO | - | 13/08/23 |
Clinton Sharples
CHM | Chairman | - | 28/05/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clinton Sharples
CHM | Chairman | - | 28/05/13 |
Céline Arsenault
BRD | Director/Board Member | - | 07/02/19 |
Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+29.76% | 5.69B | |
-32.34% | 3.53B | |
-2.23% | 3.06B | |
-25.26% | 2.62B | |
-10.88% | 2.29B | |
+40.09% | 1.86B | |
+40.90% | 1.43B | |
-15.16% | 1.41B | |
+42.86% | 1.4B |